TABLE-Stella Pharma - 9-MTH parent results

About this update from Stella Pharma Corporation

Feb 12 (Reuters)- Stella Pharma Corporation PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Dec 31, 2025 Dec 31, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 261 mln 254 mln 377 mln (+3.0 pct) (+26.9 pct) (-60.7 pct) Operating loss 512 mln loss 375 mln loss 922 mln Recurring loss 509 mln loss 371 mln loss 908 mln Net loss 512 mln loss 373 mln loss 911 mln EPS loss 15.05 yen loss 11.27 yen loss 26.80 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Stella Pharma Corporation. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T

View stock analysis, news, and events for Stella Pharma Corporation